Unbound MEDLINE

Decoupling of carbohydrate binding and MASP-2 autoactivation in variant mannose-binding lectins associated with immunodeficiency. Journal of immunology (Baltimore, Md. : 1950) [J Immunol] Journal article

 
TitleDecoupling of carbohydrate binding and MASP-2 autoactivation in variant mannose-binding lectins associated with immunodeficiency.
Author(s)Wallis R, Lynch NJ, Roscher S, Reid KB, Schwaeble WJ 
InstitutionDepartment of Infection, Immunity, and Inflammation, University of Leicester, Leicester, United Kingdom.
SourceJ Immunol 2005 Nov 15; 175(10):6846-51.
MeSHAmino Acid Substitution
Animals
Carbohydrate Metabolism
Complement Pathway, Mannose-Binding Lectin
Cricetinae
Enzyme Activation
Humans
Immunologic Deficiency Syndromes
In Vitro
Kinetics
Mannose-Binding Lectins
Mannose-Binding Protein-Associated Serine Proteases
Models, Biological
Mutagenesis, Site-Directed
Phenotype
Rats
Recombinant Proteins
Research Support, Non-U.S. Gov't
AbstractMannan-binding lectin (MBL) initiates complement activation by binding to arrays of carbohydrates on the surfaces of pathogenic microorganisms and activating MBL-associated serine proteases (MASPs). Separate point mutations to the collagenous domain of human MBL are associated with immunodeficiency, caused by reduced complement activation by the variant MBLs as well as by lower serum MBL concentrations. In the work reported here, we have used the well characterized rat lectin pathway to analyze the molecular and functional defects associated with two of the variant proteins. Mutations Gly25 --> Asp and Gly28 --> Glu create comparable structural changes in rat MBL but the G28E variant activates complement >10-fold less efficiently than the G25D variant, which in turn has approximately 7-fold lower activity than wild-type MBL. Analysis of mutant MBL . MASP-2 complexes assembled from recombinant components shows that reduced complement activation by both mutant MBLs is caused by failure to activate MASP-2 efficiently on binding to a mannan-coated surface. Disruption of MBL-MASP-2 interactions as well as to changes in oligomeric structure and reduced binding to carbohydrate ligands compared with wild-type MBL probably account for the intermediate phenotype of the G25D variant. However, carbohydrate binding and MASP-2 activation are ostensibly completely decoupled in complexes assembled from the G28E mutant, such that the rate of MASP-2 activation is no greater than the basal rate of zymogen MASP-2 autoactivation. Analogous molecular defects in human MBL probably combine to create the mutant phenotypes of immunodeficient individuals.
Languageeng
Pub Type(s)Journal Article
PubMed ID16272342
  
Advertise on this site.